Drugs / CLL1 CAR-T Cell
last change Jan 2026 re-read 3 minutes ago

CLL1 CAR-T Cell

Cell therapy

Developed for
acute myeloid leukemia
Investigated by
Donghua Zhang

Trials 1

2026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT07342244 Jan 2026 → Dec 2028 expected acute myeloid leukemia Donghua Zhang Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CLL1 CAR-T Cell ClinicalTrials.gov intervention name — accepted as the source's own label NCT07342244 ↗
Modality Cell therapy “CLL1 CAR-T Cell” NCT07342244 ↗